Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news



When you say NGO, they say conflict of interest?

2 commentsBy Annie-Rose Harrison-Dunn , 30-Jan-2014
Last updated on 30-Jan-2014 at 14:37 GMT2014-01-30T14:37:40Z

ICD said WHO is, “tending towards pulling back from collaboration with major food companies”.
ICD said WHO is, “tending towards pulling back from collaboration with major food companies”.

The World Health Organisation (WHO) decision to grant NGO status to a malnutrition-battling business alliance raised eyebrows this week, so what do organisations have to do to gain and keep such a status?

WHO granted the Global Alliance for Improved Nutrition (GAIN) NGO status after it disbanded an alliance with food and pharmaceutical firms including Coca-Cola, Cargill and GlaxoSmithKline. WHO had previously raised concerns over the nature and extent of the Alliance's link with the global food industry, a criticism some lobbyists have maintained.

John Howlett, secretary general of the Industry Council for Development (ICD), an organisation of food makers that works in the developing world and granted this special WHO status about 15 years ago, told NutraIngredients the process involved in gaining this status was a question of bureaucratic paper shuffling, but that the atmosphere surrounding this was changing.

Framework for engagement

In order to be granted NGO status, WHO requires organisations to present an outline of how its objectives are in line with its own, and how the applicant plans to implement its objectives. Once granted the status, the NGO must send a three year plan every three years detailing the objectives for the coming period as well as how the previously set objectives were fulfilled.

According to WHO’s framework for engagement with non-State actors, NGOs must demonstrate a clear benefit to public health, respect the intergovernmental nature of WHO, support and enhance the scientific and evidence-based approach that underpins WHO’s work and be actively managed so as to reduce any form of risk to WHO including conflicts of interest. WHO says overall this collaboration must be conducted on the basis of, “transparency, openness and inclusiveness”.

The health organisation also states its processes in setting norms and standards must be protected from any undue influence and that it does not engage with industries that make products directly harming human health, such as tobacco or arms.

ICD told us that an example of the objectives his organisation put forward in one of these three year reviews might be a mission of increasing resources in the areas of food safety and nutrition along with details of an annual training programme offered in South East Asia.

Paper shuffling of officialdom

Howlett said: “To my mind, it did seem a rather bureaucratic process. I was never sure someone on the other end was looking critically at it.”

He said the paperwork was often a 'copy-and-paste' from the previous year and that in the three or four renewal applications he had completed for ICD he had never felt the WHO were, “on the verge of saying it wasn’t appropriate”.

But he said the WHO appeared to be sharpening its NGO-grading claws a little.

“I do sense in the past three years WHO has become more critical,” he said. “I had the feeling they are now looking to forge closer collaborations.”

Howlett said that previously organisations could outline very broad objectives, whereas now the WHO sought more concrete day-to-day objectives.

He said WHO is, “tending towards pulling back from collaboration with major food companies”.

Profit-making logic

Baby Milk Action policy director, Patti Rundall, OBE  - a critic of the recent GAIN decision - has criticised the NGO status granted to many groups she says have overt commercial interests.

These included Croplife International (with member companies Monsanto, Syngenta, Bayer Crop Science, Dow Agrosciences, DuPont) the International Federation of Pharmaceutical Manufactures and Associations, International Life Sciences Institute (Nestlé, Coca Cola, Kellogg, Pepsi, Monsanto, Ajinomoto, Danone, General Mills and others) and the Industry Council for Development (Nestlé, Mars, Unilever and Ajinomoto) as examples.

“All are guided by market profit-making logic whose primary interest clashes with that of WHO. Their inclusion goes against WHO's current NGO policy,” she said. 

2 comments (Comments are now closed)

NGO critics should replace support and funds for WHO, if large corporations denied NGO status.

I agree that there is the perception that corporations who provide funds and support to WHO as example, have ulterior motives driven by profits. There have also been cases of pressure and coercion. However WHO and other like groups supported by responsible corporate funds and experience would lose very significant funds, and just as importantly, access to new science and technology from sponsors. So if critics believe that the corporate support and funds are "tainted" then let them replace the funds and or expertise from their own pockets, should corporations exit from such collaborations due to their actions.

Report abuse

Posted by Ian Newton
31 January 2014 | 15h302014-01-31T15:30:58Z

Conflict of Interest

Why is NUTRISEP not on the company list. They manufacture a product called PLUMPYNUT that contains 30% sugar. The product is fed to poor malnourished children all over Africa at a time when the WHO are declaring sugar is a nutritional poison that has links to many health challenges and want the intake of sugar halved.

Report abuse

Posted by Basil Kransdorff
31 January 2014 | 10h502014-01-31T10:50:42Z

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars